Inhibition of transcription factor nuclear factor-κB by a mutant inhibitor-κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death

British Journal of Cancer

Volumn 83, Issue 10, 2000, Pages 1367-1374

  Duffey, D C ^a   Crowl Bancroft, C V ^a   Chen, Z ^a   Ondrey, F G ^a   Nejad Sattari, M ^b   Dong, G ^a   Van Waes, C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Cytokins; NF B; Squamous cell carcinoma; TNF ; Transcription factors

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE; CASPASE INHIBITOR; CELL DNA; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR KAPPA B ALPHA; INHIBITOR PROTEIN; MUTANT PROTEIN; PROTEINASE; TRYPAN BLUE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DNA CONTENT; GROWTH INHIBITION; HEAD CANCER; HUMAN; HUMAN CELL; NECK CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA;

EID: 0033733631     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1423     Document Type: Article

References (64)

1. Constitutive nuclear factor-κB-Re1A activation is required for proliferation and survival of Hodgkin's disease tumor cells
2. An essential role for NF-κB in preventing TNF-α-induced cell death
3. Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function
4. Apoptotic inhibition of head and neck squamous cell carcinoma cells by tumor necrosis factor alpha
5. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
6. Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation
7. An endotoxin-induced serum factor that causes necrosis of tumors
8. Effects of IL-1α, IL-1RA and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines
9. Cytotoxicity by tumor necrosis factor is linked with the cell cycle but does not require DNA synthesis
10. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon-γ
11. The host environment promotes the constitutive activation of nuclear factor-κB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma
12. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo
13. Biologic therapy with TNF: Systemic administration and isolation-perfusion
14. Recombinant tumor necrosis factor: Species specificity for a variety of human and murine transformed cell lines
15. Tumor necrosis factor and cytotoxic agents. Effect on squamous carcinoma lines
16. NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: The role of reactive oxygen species
17. Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro
18. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress
19. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody
20. Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators
21. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max
22. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation
23. IL-1 and TNF-alpha but no IL-2 expression is found in squamous cell carcinoma of the head and neck by RT-PCR
24. Estimation of tumor necrosis factor-alpha in the diagnosis, the prognosis and the treatment follow-up of oral squamous cell carcinoma
25. Differential regulation of the c-Myc oncogene promoter by the NF-kappa B rel family of transcription factors
26. Cytotoxic mechanism of tumor necrosis factor-α
27. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis
28. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
29. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras
30. The sensitivity of head and neck squamous cell carcinomas to tumor necrosis factor-alpha
31. Constitutive activation of NF-κB during progression of breast cancer to hormone independent growth
32. Modulation with cytokines of radiation injury: Suggested mechanisms of action
33. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: A multicenter study
34. Constitutive activation of transcription factors NF-κB, AP-1 and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express proinflammatory and proangiogenic cytokines
35. Inhibition of Nuclear Factor-κB activation confers sensitivity to tumor necrosis factor-α by impairment of cell cycle progression in human glioma cells
36. Tumor necrosis factor-alpha production in human head and neck squamous cell carcinoma
37. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors
38. Antiproliferative effects of cytokines on squamous cell carcinoma
39. DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lies, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant
40. Modulation of squamous carcinoma cell growth, morphology, adhesiveness and extracellular matrix production by interferon-gamma and tumor necrosis factor-alpha
41. Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells
42. Cell cycle-dependent tumor necrosis factor apoptosis
43. Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck
44. Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro
45. Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium
46. Two TNF receptors
47. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli
48. Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity
49. Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages
50. Suppression of TNF-α-induced apoptosis by NF-κB
51. Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins
52. Rel/NF-kB/IkB family: Intimate tales of association and dissociation
53. Enhanced tumor cell expression of tumor necrosis factor receptors in head and neck squamous cell carcinoma
54. Tumor necrosis factor receptor and Fas signaling mechanisms
55. Evaluation of antitumor effect of tumor necrosis factor in terms of protein metabolism and cell cycle kinetics
56. TNF and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
57. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-1AP1 and c-1AP2 to suppress caspase-8 activation
58. Cell cycle specificity of tumor necrosis factor and its receptor
59. Induction of cell proliferation and IL-8 expression by autocrine expression of IL-1α is associated with activation of NF-κB and AP-1 in head and neck squamous cell carcinoma
60. Constitutive and cytokine induced expression of the melanoma growth stimulatory activity GRO alpha gene requires both NF-κB and novel constitutive factors
61. Inhibition of NF-kappa B/Rel induces apoptosis of murine B cells
62. IEX-IL, an apoptosis inhibitor involved in NF-κB-mediated cell survival
63. Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma
64. The prosurvival BCI-2 homolog Bf1/A1 is a direct transcriptional target of NF-kappaB that blocks TNF alpha-induced apoptosis